v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities:    
Net loss $ (91,362) $ (4,402)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 1,475 1,377
Amortization of identified intangible assets 3,358 3,142
Amortization of deferred loan origination costs 102 107
Amortization of deferred sales commissions 1,368 887
Non-cash lease expense 1,207 898
Stock compensation expense 1,458 470
Equity incentive bonus 32,863 0
Bad debt expense 110 624
Loss on disposition of asset 0 10
Deferred income tax benefit (272) (382)
Change in the fair value of warrant liability (675) 0
Offering cost associated with Warrants recorded as liabilities 41 0
Changes in assets and liabilities    
Accounts receivable (2,648) 1,892
Other assets (2,514) (405)
Deferred sales commissions (5,347) (1,985)
Accounts payable 1,725 460
Accrued expenses 1,225 1,696
Deferred revenue (54) 145
Operating lease liabilities (1,202) (904)
Other long-term liabilities (2) (5)
Net cash provided by (used in) operating activities (59,144) 3,625
Investing activities:    
Purchases of property and equipment (1,210) (434)
Acquisition of businesses, net of cash acquired 0 (20)
Asset acquisition 1,326 0
Net cash provided by (used in) investing activities 116 (454)
Financing activities:    
Proceeds from Merger and PIPE financing, net of cash paid 157,383 0
Repayment on loan payable (1,676) (864)
Repayment of drawdown on line of credit (4,672)  
Debt issuance costs (153) 0
Payment of contingent consideration liability (5,969) 0
Repayment of drawdown on line of credit   4,672
Financing cash used in finance leases (331) (582)
Net cash provided by financing activities 144,582 3,226
Effect of foreign currency translation (40) (102)
Net increase in cash, cash equivalents and restricted cash 85,514 6,295
Cash, cash equivalents, and restricted cash beginning of period 19,566 16,513
Cash, cash equivalents, and restricted cash end of period 105,080 22,808
Supplemental disclosure of cash flow information:    
Interest paid 2,828 2,836
Income taxes paid 237 181
Supplemental schedule of noncash investing activities:    
Additional right-of-use assets 3,246 997
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents:    
Cash and cash equivalents 104,980 21,348
Restricted cash, current 0 1,360
Restricted cash, net of current 100 100
Total cash, cash equivalents and restricted cash $ 105,080 $ 22,808

Source